As of April 2026, BPC-157 is not explicitly listed on the World Anti-Doping Agency (WADA) Prohibited List by name, though WADA's catch-all S0 category (non-approved substances) captures any compound without regulatory approval for human therapeutic use
Interpretation Normal levels : Reflect balanced bone turnover Elevated levels : Suggest increased bone resorption Low levels : May indicate effective anti-resorptive therapy or low osteoclast activity Because bone turnover varies with age, sex, and menopausal status, results must be compared against reference ranges
Deletion of the copper transporter CaCCC2 reveals two distinct pathways for iron acquisition in Candida albicans
The most common side effects are injection-site soreness (41%, lasting 24-36 hours), mild nausea (12-15%, lasting 4-8 hours), and skin flushing (8-10%, lasting 10-30 minutes)
PMCID: PMC7714782
While at-home administration is possible with a prescription and guidance from a qualified medical professional, self-medicating comes with substantial risks